HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
The ten-day initiative, running from 10 to 21 November, brings together a team of highly skilled German doctors providing life-changing reconstructive surgeries at no cost
AGA affects up to 80 per cent of men across their lifetime and remains one of the most common and most psychologically challenging forms of hair loss
This is the first drug to receive a recommendation for this preventative indication in the European Union
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
Subscribe To Our Newsletter & Stay Updated